• Nenhum resultado encontrado

[PDF] Top 20 TOX3 mutations in breast cancer.

Has 10000 "TOX3 mutations in breast cancer." found on our website. Below are the top 20 most common "TOX3 mutations in breast cancer.".

TOX3 mutations in breast cancer.

TOX3 mutations in breast cancer.

... these mutations might be altering or exerting still remains ...of TOX3 in an allele-specific manner ...of TOX3 with tumour grade and poorer outcome ...rs3803662 in Luminal A tumours, ... See full document

5

Identification of a comprehensive spectrum of genetic factors for hereditary breast cancer in a Chinese population by next-generation sequencing.

Identification of a comprehensive spectrum of genetic factors for hereditary breast cancer in a Chinese population by next-generation sequencing.

... loss-of-function mutations in our ...fide breast cancer susceptibility ...heightened breast cancer risk has not revealed mutations in other FA genes ...gene ... See full document

20

Prevalence of BRCA1 and BRCA2 gene mutations in families with medium and high risk of breast and ovarian cancer in Brazil

Prevalence of BRCA1 and BRCA2 gene mutations in families with medium and high risk of breast and ovarian cancer in Brazil

... genes in medium- and high-risk families indicated that, in many populations, only 30-60% of cases of hereditary breast cancer were attributed to mutations in the BRCA1 and BRCA2 ... See full document

5

The Pro allele of the p53 codon 72 polymorphism is associated with decreased intratumoral expression of BAX and p21, and increased breast cancer risk.

The Pro allele of the p53 codon 72 polymorphism is associated with decreased intratumoral expression of BAX and p21, and increased breast cancer risk.

... on in vitro ...[8,22,23,26,27]. In the most comprehensive in vitro study, 34 p53 target genes were analyzed in Saos-2 osteosarcoma cells ...[8]. In this system, PERP was induced ... See full document

10

Assessment of SLX4 Mutations in Hereditary Breast Cancers.

Assessment of SLX4 Mutations in Hereditary Breast Cancers.

... SLX4 in familial BRCA1/2 mutation-negative breast cancer ...missense mutations in 52 patients (28 German and 24 Byelorussian) [18]. In the second study, consisting of 526 ... See full document

5

PIK3CA and TP53 gene mutations in human breast cancer tumors frequently detected by ion torrent DNA sequencing.

PIK3CA and TP53 gene mutations in human breast cancer tumors frequently detected by ion torrent DNA sequencing.

... Breast cancer is the most common malignancy and the leading cause of cancer deaths in women ...genetic mutations have been linked to 5–10% of breast cancer cases, other ... See full document

9

Centro de Pesquisa em Oncologia Molecular, Hospital de Câncer de Barretos, Barretos, SP, Brazil

Centro de Pesquisa em Oncologia Molecular, Hospital de Câncer de Barretos, Barretos, SP, Brazil

... 54 cancer-unaffected and at-risk patients ...frequent cancer site was breast, and as ex- pected, the majority of these diagnoses were made before the age of 50 ...ovarian cancer (one HBOC and ... See full document

13

POLIMORFISMO NO GENE HER2 NO CANCRO DA MAMA E DO OVÁRIO

POLIMORFISMO NO GENE HER2 NO CANCRO DA MAMA E DO OVÁRIO

... Breast cancer is a major public health problem around the world, and its carcinogenesis is not yet well ...role in the development of this neoplasia, and genetic alterations in this gene, such ... See full document

96

POLIMORFISMO NO GENE HER2 NO CANCRO DA MAMA E DO OVÁRIO

POLIMORFISMO NO GENE HER2 NO CANCRO DA MAMA E DO OVÁRIO

... Breast cancer is a major public health problem around the world, and its carcinogenesis is not yet well ...role in the development of this neoplasia, and genetic alterations in this gene, such ... See full document

96

A genomewide screen for suppressors of Alu-mediated rearrangements reveals a role for PIF1.

A genomewide screen for suppressors of Alu-mediated rearrangements reveals a role for PIF1.

... high-risk breast cancer families are not explained by mutations in known genes, indicating that still unidentified genes may explain cancer risk in these ...variation in ... See full document

10

Prevalence and impact of founder mutations in hereditary breast cancer in Latin America

Prevalence and impact of founder mutations in hereditary breast cancer in Latin America

... founder mutations in breast cancer predisposition genes appear to be common in several Latin American ...founder mutations appear to be selectively present in only one or ... See full document

7

Differential epigenetic regulation of TOX subfamily high mobility group box genes in lung and breast cancers.

Differential epigenetic regulation of TOX subfamily high mobility group box genes in lung and breast cancers.

... and TOX3 by 70– 86% (Figure 5A and ...expression in normal and cancer ...beta-actin in distant normal lung tissue (DNLT), HBEC, and various lung and breast cancer cell ...lines. ... See full document

11

Detection of actionable mutations in ctDNA in advanced breast cancer patients

Detection of actionable mutations in ctDNA in advanced breast cancer patients

... Portugal in order to receive treatment for a locally advanced tumor of the right ...brightfield in situ hybridization ...disease. Breast lesion was re-biopsied (table 3) and the patient started ... See full document

57

Clinics  vol.67 número11

Clinics vol.67 número11

... Brazilian breast cancer patients. In this study, we identified PIK3CA mutations in primary breast tumors from a group of Brazilian breast cancer patients and ... See full document

6

Oncogenetics service and the Brazilian public health system: the experience of a reference Cancer Hospital

Oncogenetics service and the Brazilian public health system: the experience of a reference Cancer Hospital

... tions in genes related to hereditary predisposition cancer syndromes is crucial for targeting specific behaviors of cancer screening, such as early diagnosis and ...treatment. In the case of ... See full document

10

Cad. Saúde Pública  vol.24 número4

Cad. Saúde Pública vol.24 número4

... ics in one of the selected referral ...diagnoses in smaller proportions. Patients with a history or suspicion of breast cancer at the time of inter- view or who had any disease that was ... See full document

9

Rev. Hosp. Clin.  vol.58 número2

Rev. Hosp. Clin. vol.58 número2

... between breast cancer and ...Factor in Breast Cancer reanalyzed data from 53,865 postmenopausal women, of whom 17,830 (33%) had used HRT at some ...having breast cancer of ... See full document

6

Association between 5p12 genomic markers and breast cancer susceptibility: evidence from 19 case-control studies.

Association between 5p12 genomic markers and breast cancer susceptibility: evidence from 19 case-control studies.

... analyses in other ethnicities is ...inflated. In this context, more reliable results can be expected if individual data are available for a pooled ... See full document

8

Rev. Assoc. Med. Bras.  vol.59 número3

Rev. Assoc. Med. Bras. vol.59 número3

... osteoporosis in the cancerous patient is very ...Indeed, cancer therapy should also be focused on mon- itoring osteoporosis among cancerous ...therapy in breast can- cer is quite ... See full document

1

Cytogenetic evaluation of 20 primary breast carcinomas

Cytogenetic evaluation of 20 primary breast carcinomas

... Breast cancer is the most common neoplasm and the leading cause of cancer related deaths among women in most countries (PARKIN et al. The natural history of breast cancer va[r] ... See full document

8

Show all 10000 documents...